Literature DB >> 27444064

Pancreatic cancer biology and genetics from an evolutionary perspective.

Alvin Makohon-Moore1,2, Christine A Iacobuzio-Donahue2,3,4.   

Abstract

Cancer is an evolutionary disease, containing the hallmarks of an asexually reproducing unicellular organism subject to evolutionary paradigms. Pancreatic ductal adenocarcinoma (hereafter referred to as pancreatic cancer) is a particularly robust example of this phenomenon. Genomic features indicate that pancreatic cancer cells are selected for fitness advantages when encountering the geographic and resource-depleted constraints of the microenvironment. Phenotypic adaptations to these pressures help disseminated cells to survive in secondary sites, a major clinical problem for patients with this disease. In this Review we gather the wide-ranging aspects of pancreatic cancer research into a single concept rooted in Darwinian evolution, with the goal of identifying novel insights and opportunities for study.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27444064      PMCID: PMC5739515          DOI: 10.1038/nrc.2016.66

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  139 in total

Review 1.  High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and meta-analysis.

Authors:  Xi-Jun Cui; Qiang He; Jian-Min Zhang; Hui-Jie Fan; Zheng-Fang Wen; Yan-Ru Qin
Journal:  Pancreas       Date:  2014-01       Impact factor: 3.327

2.  Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

3.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

4.  Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations.

Authors:  L Gorunova; M Höglund; A Andrén-Sandberg; S Dawiskiba; Y Jin; F Mitelman; B Johansson
Journal:  Genes Chromosomes Cancer       Date:  1998-10       Impact factor: 5.006

5.  Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.

Authors:  Linghua Wang; Shuichi Tsutsumi; Tokuichi Kawaguchi; Koichi Nagasaki; Kenji Tatsuno; Shogo Yamamoto; Fei Sang; Kohtaro Sonoda; Minoru Sugawara; Akio Saiura; Seiko Hirono; Hiroki Yamaue; Yoshio Miki; Minoru Isomura; Yasushi Totoki; Genta Nagae; Takayuki Isagawa; Hiroki Ueda; Satsuki Murayama-Hosokawa; Tatsuhiro Shibata; Hiromi Sakamoto; Yae Kanai; Atsushi Kaneda; Tetsuo Noda; Hiroyuki Aburatani
Journal:  Genome Res       Date:  2011-12-07       Impact factor: 9.043

6.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-01-02       Impact factor: 47.728

Review 7.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

8.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).

Authors:  Utz Herbig; Wendy A Jobling; Benjamin P C Chen; David J Chen; John M Sedivy
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

9.  Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression.

Authors:  Walter M Klein; Ralph H Hruban; Andres J P Klein-Szanto; Robb E Wilentz
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

10.  Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Authors:  Brian M Wolpin; Cosmeri Rizzato; Peter Kraft; Charles Kooperberg; Gloria M Petersen; Zhaoming Wang; Alan A Arslan; Laura Beane-Freeman; Paige M Bracci; Julie Buring; Federico Canzian; Eric J Duell; Steven Gallinger; Graham G Giles; Gary E Goodman; Phyllis J Goodman; Eric J Jacobs; Aruna Kamineni; Alison P Klein; Laurence N Kolonel; Matthew H Kulke; Donghui Li; Núria Malats; Sara H Olson; Harvey A Risch; Howard D Sesso; Kala Visvanathan; Emily White; Wei Zheng; Christian C Abnet; Demetrius Albanes; Gabriella Andreotti; Melissa A Austin; Richard Barfield; Daniela Basso; Sonja I Berndt; Marie-Christine Boutron-Ruault; Michelle Brotzman; Markus W Büchler; H Bas Bueno-de-Mesquita; Peter Bugert; Laurie Burdette; Daniele Campa; Neil E Caporaso; Gabriele Capurso; Charles Chung; Michelle Cotterchio; Eithne Costello; Joanne Elena; Niccola Funel; J Michael Gaziano; Nathalia A Giese; Edward L Giovannucci; Michael Goggins; Megan J Gorman; Myron Gross; Christopher A Haiman; Manal Hassan; Kathy J Helzlsouer; Brian E Henderson; Elizabeth A Holly; Nan Hu; David J Hunter; Federico Innocenti; Mazda Jenab; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Eric A Klein; Manolis Kogevinas; Vittorio Krogh; Juozas Kupcinskas; Robert C Kurtz; Andrea LaCroix; Maria T Landi; Stefano Landi; Loic Le Marchand; Andrea Mambrini; Satu Mannisto; Roger L Milne; Yusuke Nakamura; Ann L Oberg; Kouros Owzar; Alpa V Patel; Petra H M Peeters; Ulrike Peters; Raffaele Pezzilli; Ada Piepoli; Miquel Porta; Francisco X Real; Elio Riboli; Nathaniel Rothman; Aldo Scarpa; Xiao-Ou Shu; Debra T Silverman; Pavel Soucek; Malin Sund; Renata Talar-Wojnarowska; Philip R Taylor; George E Theodoropoulos; Mark Thornquist; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Pavel Vodicka; Jean Wactawski-Wende; Nicolas Wentzensen; Chen Wu; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Robert Hoover; Patricia Hartge; Charles Fuchs; Stephen J Chanock; Rachael S Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Nat Genet       Date:  2014-08-03       Impact factor: 41.307

View more
  132 in total

1.  Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.

Authors:  Yi Qin; Qiangsheng Hu; Shunrong Ji; Jin Xu; Weixing Dai; Wensheng Liu; Wenyan Xu; Qiqing Sun; Zheng Zhang; Quanxing Ni; Xianjun Yu; Bo Zhang; Xiaowu Xu
Journal:  Cell Prolif       Date:  2019-04-01       Impact factor: 6.831

Review 2.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

3.  Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Bhavitavya Nijampatnam; Sadanandan E Velu; Ke-He Ruan; Ming Hu; Jianwei Zhou; Ruiwen Zhang
Journal:  Cancer Res       Date:  2018-09-14       Impact factor: 12.701

Review 4.  Metabolic Interactions in the Tumor Microenvironment.

Authors:  Costas A Lyssiotis; Alec C Kimmelman
Journal:  Trends Cell Biol       Date:  2017-07-19       Impact factor: 20.808

5.  A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.

Authors:  Nguyen Phuoc Long; Sang Jun Yoon; Nguyen Hoang Anh; Tran Diem Nghi; Dong Kyu Lim; Yu Jin Hong; Soon-Sun Hong; Sung Won Kwon
Journal:  Metabolomics       Date:  2018-08-10       Impact factor: 4.290

6.  Pancreatic cancer: Pancreatic carcinogenesis - several small steps or one giant leap?

Authors:  Johannes G Reiter; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-22       Impact factor: 46.802

7.  Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases.

Authors:  Matthew E Bechard; Anna E Word; Amanda V Tran; Xiaojing Liu; Jason W Locasale; Oliver G McDonald
Journal:  Oncogene       Date:  2018-05-30       Impact factor: 9.867

8.  Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells.

Authors:  Zeng Ye; Qiangsheng Hu; Qifeng Zhuo; Yuemeng Zhu; Guixiong Fan; Mengqi Liu; Qiqing Sun; Zheng Zhang; Wensheng Liu; Wenyan Xu; Shunrong Ji; Xianjun Yu; Xiaowu Xu; Yi Qin
Journal:  Am J Cancer Res       Date:  2020-04-01       Impact factor: 6.166

9.  Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.

Authors:  Alvin P Makohon-Moore; Ming Zhang; Johannes G Reiter; Ivana Bozic; Benjamin Allen; Deepanjan Kundu; Krishnendu Chatterjee; Fay Wong; Yuchen Jiao; Zachary A Kohutek; Jungeui Hong; Marc Attiyeh; Breanna Javier; Laura D Wood; Ralph H Hruban; Martin A Nowak; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nat Genet       Date:  2017-01-16       Impact factor: 38.330

10.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.